Manchester Capital Management LLC 10x Genomics, Inc. Transaction History
Manchester Capital Management LLC
- $829 Million
- Q3 2024
A detailed history of Manchester Capital Management LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Manchester Capital Management LLC holds 4 shares of TXG stock, worth $58. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4
Previous 4
-0.0%
Holding current value
$58
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TXG
# of Institutions
291Shares Held
94.7MCall Options Held
263KPut Options Held
85.1K-
Vanguard Group Inc Valley Forge, PA11MShares$161 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$158 Million2.31% of portfolio
-
Morgan Stanley New York, NY6.48MShares$95 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$93.8 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.37MShares$93.5 Million0.1% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.39B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...